CDC recommends new booster shots to fight omicron
CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.
COVID-19 vaccine
'My body, my choice': How vaccine foes co-opted the abortion rallying cry
Anti-vaccine advocates have repurposed a catchy, succinct, and potent slogan. Its unlikely source: the reproductive rights movement, which has been linked to the phrase for more than 50 years.
FDA says COVID boosters for the fall must target newer omicron types
With immunity waning and the super-contagious omicron family of variants getting better at dodging protection, the Food and Drug Administration decided boosters intended for fall needed an update.
COVID vaccines are finally here for young kids. But the logistics aren't easy
NPR talks to Claire Hannan, who has helped navigate vaccine rollouts in all 50 states, about some of the challenges involved in quickly getting shots out to millions of young kids.
The FDA authorizes COVID-19 shots for infants and preschoolers
The vaccinations for children as young as 6 months old could start next week. But first, the Centers for Disease Control and Prevention must sign off.
Novavax's COVID vaccine nears the finish line
The Novavax vaccine appears to be about 90% effective at preventing mild, moderate and severe COVID-19, Food and Drug Administration scientists say in an analysis of the company's data.
Advisers to FDA weigh in on updated COVID boosters for the fall
The vaccines now in use are based on the form of the virus that circulated at the beginning of the pandemic and are less effective against the omicron variant. New options are in the works.
Evidence grows that vaccines lower the risk of getting long COVID
Though findings are preliminary, many studies suggest that vaccinated people have good protection against the condition, although just how much is still up for debate.
Moderna seeks approval for a 2nd COVID-19 booster shot for adults
If approved, this would be the second booster shot Moderna has issued for people ages 18 and up.
The FDA postpones a highly anticipated meeting on the Pfizer vaccine for young kids
"We believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization," FDA officials said in a statement.